بدائل البحث:
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), nn decrease (توسيع البحث), mean decrease (توسيع البحث)
ng decrease » nn decrease (توسيع البحث), _ decrease (توسيع البحث), gy decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
50 ng » 50 mg (توسيع البحث), 10 ng (توسيع البحث), 5 ng (توسيع البحث)
teer decrease » mean decrease (توسيع البحث), greater decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), nn decrease (توسيع البحث), mean decrease (توسيع البحث)
ng decrease » nn decrease (توسيع البحث), _ decrease (توسيع البحث), gy decreased (توسيع البحث)
a decrease » _ decrease (توسيع البحث), _ decreased (توسيع البحث), _ decreases (توسيع البحث)
50 ng » 50 mg (توسيع البحث), 10 ng (توسيع البحث), 5 ng (توسيع البحث)
-
61
Image5_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.TIFF
منشور في 2024"…The COVID-19 pandemic resulted in a statistically significant decrease in lung cancer incidence, especially in the 50–59 age group (both sexes).…"
-
62
-
63
-
64
-
65
Advancing the science of NOWS research.
منشور في 2024"…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"
-
66
Protocol measures.
منشور في 2024"…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"
-
67
Cry variables.
منشور في 2024"…<div><p>Every 15 minutes in the US, an infant exposed to opioids is born. Approximately 50% of these newborns will develop Neonatal Opioid Withdrawal Syndrome (NOWS) within 5 days of birth. …"
-
68
-
69
-
70
-
71
-
72
Flow chart of the study procedures.
منشور في 2023"…Pre-treatment spontaneous decrease of RPR titer was associated with a slower decrease in post-treatment RPR titer.…"
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
Discovery of the Triazolo[1,5‑<i>a</i>]Pyrimidine-Based Derivative WS-898 as a Highly Efficacious and Orally Bioavailable ABCB1 Inhibitor Capable of Overcoming Multidrug Resistance...
منشور في 2021"…Here, we reported our medicinal chemistry efforts that led to the discovery of the triazolo[1,5-<i>a</i>]pyrimidine derivative <b>WS-898</b> as a highly effective ABCB1 inhibitor capable of reversing paclitaxel (PTX) resistance in drug-resistant SW620/Ad300, KB-C2, and HEK293/ABCB1 cells (IC<sub>50</sub> = 5.0, 3.67, and 3.68 nM, respectively), more potent than verapamil and zosuquidar. …"